Prelude Therapeutics Inc - COMMON STOCK (PRLD)
CUSIP: 74065P101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 80,844,194
- Total 13F shares
- 27,187,955
- Share change
- -3,081,731
- Total reported value
- $21,995,839
- Price per share
- $0.81
- Number of holders
- 49
- Value change
- -$2,401,932
- Number of buys
- 20
- Number of sells
- 35
Quarterly Holders Quick Answers
What is CUSIP 74065P101?
CUSIP 74065P101 identifies PRLD - Prelude Therapeutics Inc - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74065P101:
Top shareholders of PRLD - Prelude Therapeutics Inc - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
13%
|
10,909,256
|
$8,378,309 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
13%
|
10,123,824
|
$7,775,097 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.23%
|
187,613
|
$3,617,179 | — | 31 Mar 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
2.6%
|
2,108,014
|
$1,623,171 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.3%
|
1,047,725
|
$804,652 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
1,009,204
|
$775,068 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
976,147
|
$750,000 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.81%
|
656,700
|
$504,346 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.65%
|
529,327
|
$405,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.5%
|
404,955
|
$311,046 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.37%
|
302,779
|
$232,535 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.35%
|
286,046
|
$219,683 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.32%
|
260,400
|
$199,987 | — | 31 Mar 2025 | |
| Laurent Chardonnet |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
192,165
mixed-class rows
|
$158,962 | — | 01 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
183,667
|
$141,056 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.2%
|
160,652
|
$123,381 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.19%
|
155,215
|
$119,205 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.18%
|
146,770
|
$112,719 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
116,907
|
$89,784 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.14%
|
114,050
|
$87,590 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.12%
|
96,156
|
$73,848 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
88,500
|
$67,968 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
80,723
|
$62,157 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
77,870
|
$59,804 | — | 31 Mar 2025 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.09%
|
69,252
|
$53,186 | — | 31 Mar 2025 | |
| Marex Group plc |
13F
|
Company |
0.07%
|
56,270
|
$43,215 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.05%
|
41,846
|
$32,000 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.04%
|
34,565
|
$26,546 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
33,823
|
$25,976 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
28,613
|
$21,975 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
24,700
|
$18,970 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
23,780
|
$18,264 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
23,145
|
$17,776 | — | 31 Mar 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.03%
|
20,630
|
$17,536 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.03%
|
20,238
|
$15,543 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.02%
|
19,668
|
$15,105 | — | 31 Mar 2025 | |
| Christopher Pierce |
3/4/5
|
EVP and Chief of Business Oper |
—
mixed-class rows
|
211,546
mixed-class rows
|
$14,138 | — | 02 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.02%
|
17,251
|
$13,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
15,499
|
$11,894 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
15,446
|
$11,862 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
13,586
|
$10,434 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
9,300
|
$7,142 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
7,912
|
$6,076 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
7,887
|
$6,057 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
6,458
|
$4,960 | — | 31 Mar 2025 | |
| Militia Capital Partners, LP |
13F
|
Company |
0.01%
|
4,300
|
$3,302 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
3,346
|
$3,000 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
3,622
|
$2,782 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
2,741
|
$2,105 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,544
|
$2,000 | — | 31 Mar 2025 |
Institutional Holders of Prelude Therapeutics Inc - COMMON STOCK (PRLD) as of Q2 2025
As of 30 Jun 2025,
Prelude Therapeutics Inc - COMMON STOCK (PRLD) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,187,955 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, RENAISSANCE TECHNOLOGIES LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, and TWO SIGMA ADVISERS, LP.
This page lists
49
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
56
Q2 2025 holders
49
Holder diff
-7
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.